Tag: AUGUSTUS

Stephan Windecker presents preferred strategies with Apixaban

TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy...

A prespecified analysis of data from the AUGUSTUS study, released at late-breaking session at the Transcatheter Cardiovascular Therapeutics scientific symposium (TCT 2019; 25–29 September,...